Nordic Nanovector Strengthens Management Team with Appointment of Maureen Deehan, PhD, as Head of Corporate Development and Strategy
(WorldNews Norway)

Oslo, Norway, 1 June 2018 Nordic Nanovector ASA (OSE: NANO) announces that Maureen Deehan, PhD, has been appointed as Head of Corporate Development and Strategy. Maureen will work alongside Chief Operating Officer Marco Renoldi on the development and execution of the Company`s corporate development strategy. Maureen has 25 years` experience in business development, clinical development and translational biology. Prior to her appointment, Maureen served for seven years at Novimmune, a Swiss biotech company developing antibody-based drugs for...